The company revealed plans to delist from the Canadian Exchange, citing cost savings and improved liquidity on NASDAQ.

And that would be a fine development for Curaleaf and the rest of the ever-struggling marijuana industry. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position ...

Germany became the world's top importer of medical cannabis, but political pressure could challenge telehealth-driven growth.

Canopy Growth is a pure-play cannabis company that falls into multiple categories. It started as a Canadian licensed producer ...

Marijuana stocks may seem a tempting investment, but make sure you're aware of the associated risks before diving into this burgeoning market. Many, or all, of the products featured on this page ...

It exceeded the consensus estimates in each of the last four quarters. Among the 17 analysts covering the stock, the consensus rating is a “Strong Buy” which is based on 11 “Strong Buy ...

Among the 14 analysts covering the stock, the consensus rating is a “Strong Buy.” That’s based on nine “Strong Buy” ratings, two “Moderate Buys,” and three “Holds.” On May 13 ...

Terrance Cole, President Trump's nominee for DEA Administrator, largely sidestepped questions from two Democratic senators regarding marijuana reforms. Sens. Cory Booker (N.J.) and Alex Padilla (Calif ...

Share prices of Arm Holdings (NASDAQ: ARM) initially sank following the cautious outlook it issued with its fiscal 2025 fourth-quarter results on Wednesday, May 7, but the stock has rallied back ...

Given the recent volatility the stock has seen, let's take a closer look at the semiconductor company's most recent earnings results and guidance to see what investors should do with their shares.

UnitedHealth also suspended its 2025 financial outlook, citing unexpectedly high ... first few minutes of trading on Tuesday morning. The stock had already sunk by one-quarter this year after ...

The health insurer also suspended its full-year outlook as Medicare Advantage costs remained higher than expected. Shares sank 13% Tuesday morning, with other health insurer stocks also declining.